A I El Sony1, C-Y Chiang2, E Malik3, S A Hassanain1, H Hussien1, A H Khamis4, A F Bassilli5, D A Enarson6. 1. Epi-Lab, Khartoum, Sudan. 2. International Union Against Tuberculosis and Lung Disease, Paris, France ; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan ; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. 3. Ministry of Health, Madani, Gezira State, Sudan. 4. Epi-Lab, Khartoum, Sudan ; Department of Family and Community Medicine, University of Dammam, Khobar, Saudi Arabia. 5. World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt. 6. International Union Against Tuberculosis and Lung Disease, Paris, France.
Abstract
SETTING: A pilot project for asthma management in selected hospitals in Khartoum and Gezira States, Sudan. OBJECTIVE: To assess standard case management of asthma in 2007-2008. DESIGN: Local adaptation of guidelines, followed by situational analysis, pre-intervention study, training and implementation. Treatment outcome was assessed 1 year after patient enrolment. RESULTS: Situational analysis revealed that inhaled beclometasone was not available in the public sector. During the project, 2068 patients were enrolled: severity of asthma was intermittent in 185 (9.0%), mild persistent in 231 (11.2%), moderate persistent in 640 (31.0%), severe persistent in 812 (39.3%) and unclassified in 200 (9.7%). Of the 1654 patients with persistent asthma who were treated with inhaled corticosteroids, 1157 (70.0%) had treatment cards available for outcome assessment. Of these, 652 (56.4%) did not attend their annual evaluation, among whom 1 (0.1%) died and 651 (56.3%) were lost to follow-up. Of the 505 patients who attended their annual evaluation, 417 (82.6%) improved, 32 (6.3%) were stable and 56 (11.1%) were worse. The frequency of emergency visits and hospitalisation decreased substantially among those who presented for the 1 year follow-up assessment. CONCLUSION: The results of standard case management of asthma were encouraging; however, a high proportion of patients did not return for long-term management.
SETTING: A pilot project for asthma management in selected hospitals in Khartoum and Gezira States, Sudan. OBJECTIVE: To assess standard case management of asthma in 2007-2008. DESIGN: Local adaptation of guidelines, followed by situational analysis, pre-intervention study, training and implementation. Treatment outcome was assessed 1 year after patient enrolment. RESULTS: Situational analysis revealed that inhaled beclometasone was not available in the public sector. During the project, 2068 patients were enrolled: severity of asthma was intermittent in 185 (9.0%), mild persistent in 231 (11.2%), moderate persistent in 640 (31.0%), severe persistent in 812 (39.3%) and unclassified in 200 (9.7%). Of the 1654 patients with persistent asthma who were treated with inhaled corticosteroids, 1157 (70.0%) had treatment cards available for outcome assessment. Of these, 652 (56.4%) did not attend their annual evaluation, among whom 1 (0.1%) died and 651 (56.3%) were lost to follow-up. Of the 505 patients who attended their annual evaluation, 417 (82.6%) improved, 32 (6.3%) were stable and 56 (11.1%) were worse. The frequency of emergency visits and hospitalisation decreased substantially among those who presented for the 1 year follow-up assessment. CONCLUSION: The results of standard case management of asthma were encouraging; however, a high proportion of patients did not return for long-term management.
Authors: Neil Pearce; Innes Asher; Nils Billo; Karen Bissell; Philippa Ellwood; Asma El Sony; Luis García-Marcos; Chen-Yuan Chiang; Javier Mallol; Guy Marks; David Strachan Journal: Lancet Respir Med Date: 2013-04-05 Impact factor: 30.700
Authors: N Ait-Khaled; J Odhiambo; N Pearce; K S Adjoh; I A Maesano; B Benhabyles; Z Bouhayad; E Bahati; L Camara; C Catteau; A El Sony; F O Esamai; I E Hypolite; K Melaku; O A Musa; L Ng'ang'a; B O Onadeko; O Saad; M Jerray; J M Kayembe; N B Koffi; F Khaldi; C Kuaban; K Voyi; J M'Boussa; O Sow; O Tidjani; H J Zar Journal: Allergy Date: 2007-03 Impact factor: 13.146
Authors: S F Kodouda; R Zachariah; M Khogali; J van Griensven; M Saeed; E Hussein Ibrahim; S Schneider; S Adulazeem; H A El Sadig; R Atta; N Gafar Mahgoub; A I El Sony Journal: Public Health Action Date: 2014-06-21
Authors: Karen Bissell; Philippa Ellwood; Eamon Ellwood; Chen-Yuan Chiang; Guy B Marks; Asma El Sony; Innes Asher; Nils Billo; Christophe Perrin Journal: Int J Environ Res Public Health Date: 2019-02-19 Impact factor: 3.390